Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Hedge fund Glenview off 30% as coronavirus weighs on portfolio

Published 04/03/2020, 02:09 PM
Updated 04/03/2020, 11:35 PM
© Reuters. Larry Robbins, Founder, CEO and Portfolio Manager for Glenview Capital Management, LLC speaks during the 2019 Sohn Investment Conference in New York

By Svea Herbst-Bayliss

BOSTON (Reuters) - Glenview Capital Management, the hedge fund run by Larry Robbins, has lost roughly 30% in the first three months of 2020 as the spread of the new coronavirus hurt the healthcare facilities and hospital operators the firm has invested in.

The $6.7 billion firm, which invests heavily in healthcare stocks, said this week that its Glenview Capital Partners fund tumbled 19.5% in March, leaving it down 30.48% in the first three months of the year, according to data compiled by investment firm HSBC and seen by Reuters.

Last year the fund returned 26.28%.

By comparison data from Hedge Fund Research shows that the average global hedge fund lost 5.88% in March, leaving it down 6.85% for the first three months.

A spokesman for Glenview declined to comment.

Robbins' heavily healthcare-focused portfolio performed well in the wake of healthcare overhaul in the United States. Insurers and healthcare facility operators had gotten a boost when the Affordable Care Act was signed into law in 2010 as more coverage was expected to help their returns. But the spread of the novel coronavirus is straining hospitals and healthcare facilities, and is now weighing on the portfolio.

Healthcare facilities are being swamped with sick patients, including many elderly who are on lower paying Medicare health insurance, and are being forced to postpone more lucrative elective surgeries.

Healthcare facilities operator HCA (NYSE:HCA) Healthcare Inc ranked as Glenview's biggest investment at the end of the last year. This year, stock price has fallen 45%. Hospital operator Tenet Healthcare Corp (NYSE:THC), whose stock has lost 67% since January, ranked as Glenview's third-largest investment at the end of 2019, according to a regulatory filing.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Glenview has been watching the spread of the new coronavirus for weeks and was among a handful of prominent firms to take action in late February when it announced that it was postponing an investor conference planned for April 22.

The firm said it hoped to host the event at a later date in 2020.

Glenview isn't the only prominent hedge fund firm to suffer losses this year, hedge fund industry investors said. David Einhorn's Greenlight Capital lost 21.5% in the first quarter after a 12% drop in March and Daniel Loeb's Third Point Offshore Fund fell 11% in March, leaving it down 16% for the first quarter.

Spokespeople for the firms declined to comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.